arrow
G

Gaspar Reynés

No institution found
H指数:18
被引数:1,350

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct protein and metabolic profiles in patients with advanced clear-cell renal cell carcinoma treated with sunitinib: a study of the Spanish oncology genitourinary group

晚期透明细胞肾细胞癌患者接受舒尼替尼治疗后的差异蛋白和代谢谱:西班牙泌尿生殖肿瘤学组的研究

2026-04-290
OAAI
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study
2019-10-2621
OAAI
Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers
2019-07-010
PRE
Radium-223 international early access program: results from the Spanish subset
2017-12-133
PREAI
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
2017-01-247
OAAI
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
2016-02-0348
PREAI
GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation
2015-09-011
PREAI
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
2013-05-3025
OAAI